Developer docs
API playgroundTry for free, no card

Search company profiles

Syntermed

Full company profile

uuid000czdd

Namestring
Syntermed
Legal namestring
Syntermed, Inc.
Websiteurl
syntermed.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Syntermed, Inc. is a privately-held medical imaging software company founded in 1999 and headquartered in Atlanta, Georgia. The company develops FDA-cleared quantitative analysis software for SPECT, PET, and CT imaging of the heart and brain, serving cardiology, nuclear medicine, radiology, and oncology practices worldwide. Its core product lines include the Emory Cardiac Toolbox (now rebranded as Cardiac Toolbox/eCTB after Syntermed acquired full IP rights in September 2025) for myocardial perfusion, calcium scoring, strain analysis, blood flow, and dyssynchrony assessment; NeuroQ for FDG-PET, Amyloid, SPECT, DaTscan, and Epilepsy brain quantification against a 240-region reference database; aPROMISE, the only FDA-cleared deep-learning application for standardized PSMA PET/CT quantification in prostate cancer; and Syntermed Live, a HIPAA-compliant cloud platform for remote reading and reporting that has hosted nearly one million studies since its 2007 launch. Supporting modules include SmartReport and Syntermed IDS for natural language structured reporting and clinical decision support (230-rule engine), SyncTool, FlowTool, AdreView Tools, and amyloidosis analysis.

Syntermed generates revenue primarily through software licensing and subscriptions sold directly, through value-added resellers, and via OEM embedding arrangements with GE Medical Systems, Siemens, Philips, Canon Medical, Spectrum Dynamics, and other imaging manufacturers. The Master Service Agreement indicates recurring subscription fees with annual billing in advance and automatic renewal, supplemented by professional services (training, installation) and 24/7 support under maintenance plans. The company holds FDA 510(k) clearances, ISO 13485:2016 certification (FM 670241), CE Mark 696491, and HIPAA compliance, and Ken Van Train has guided 22 successful 510(k) submissions. Funding has historically come from operations plus over $3.3 million in NIH SBIR/STTR grants rather than external venture capital.

The company has 11-50 employees and operates globally through a combined OEM-embedded, direct enterprise sales, and event-driven GTM motion, with active participation at SNMMI and partnerships with IAEA, Lantheus (PYLARIFY AI), ASNC ImageGuide Registry, and academic institutions including Emory University and UCLA. Leadership includes Michael Lee (Chairman and CEO), Ken Van Train (President, founder-era), and Ernest V. Garcia, PhD (Chief Scientific Advisor and Endowed Professor at Emory) as the principal scientific anchor behind the cardiac algorithms.

Short descriptiontext

Syntermed is an Atlanta-based medical imaging software company founded in 1999 that develops FDA-cleared quantitative analysis software for SPECT, PET, and CT imaging of the heart and brain, distributed globally through major OEMs (GE, Siemens, Philips, Canon) and value-added resellers to cardiology, nuclear medicine, radiology, and oncology practices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAtlanta, United States
HQ citystring
Atlanta
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
nuclear cardiology software, medical imaging analytics, brain imaging quantification, cardiac SPECT PET analysis, radiology decision support
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAE
Nuclear Medicine & Molecular Imaging (SPECT/PET)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKABAE
Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Nuclear Cardiology Imaging Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Software Licensing and Subscriptions
TypeSubscription Recurring
Description

Syntermed licenses its medical imaging software products (Emory Toolbox, NeuroQ) through OEM partnerships, direct sales, and value-added resellers. The Master Service Agreement indicates recurring subscription fees with automatic renewal terms and per-order pricing structures.

syntermed.com
2Professional Services and Support
TypeProfessional Services
Description

Training, installation, and technical support services including on-site training for additional fees and 24/7 support for customers on Software Maintenance Plans.

syntermed.com
3OEM/Embedded Licensing
TypeLicensing Royalties
Description

Software embedded and integrated by OEM partners including GE, Siemens, Philips, Canon Medical, and others for distribution with their imaging systems.

syntermed.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise/Lab Licensing
ModelSubscriptionBilling cadenceAnnual
Notes

Fixed recurring charges invoiced in advance with automatic renewal terms. Pricing negotiated per order.

syntermed.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 6 records shown
1Cardiac Toolbox
Description

Advanced multi-modality solution for nuclear cardiology imaging analysis, formerly known as Emory Cardiac Toolbox. Provides tools for SPECT, PET, CT, reporting, CFR, and remote reading.

syntermed.com
+5 more records
Core offering1 text field

Syntermed develops, licenses, and supports FDA-cleared medical imaging software for the quantitative analysis of SPECT, PET, and CT scans of the heart and brain. Its flagship offerings include the Emory Cardiac Toolbox (Cardiac Toolbox / eCTB) for nuclear cardiology, NeuroQ for brain imaging quantification, Syntermed Live for cloud-based remote reading, and aPROMISE for PSMA PET/CT prostate cancer assessment. The company distributes its software through OEM imaging system providers, value-added resellers, and direct sales to cardiology, nuclear medicine, and radiology labs worldwide.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Dementia diagnostic accuracy increases from ~70% visual read to ~90% with FDG-PET + NeuroQ quantification
+3 more records
Product overview1 text field

Syntermed is a medical imaging software company offering a platform of specialized products for nuclear cardiology, neuroradiology, and oncology imaging analysis. The core products include Emory Cardiac Toolbox/Cardiac Toolbox (eCTB) for cardiovascular imaging quantification, NeuroQ for brain imaging analysis, and Syntermed Live for cloud-based remote reading. Additional specialized modules include SmartReport and Syntermed IDS for automated reporting and clinical decision support, SyncTool and FlowTool for cardiac dyssynchrony and blood flow analysis, AdreView Tools for sympathetic innervation imaging, Calcium Scoring and Amyloidosis Analysis for cardiac CT/PET analysis, and aPROMISE for PSMA PET/CT quantification in oncology. The company also provides advanced brain imaging tools including EQuAL for epilepsy planning, Serial Compare for longitudinal studies, DaTscan Analysis, and Amyloid Analysis within the NeuroQ platform.

Product and service11 records
1Emory Cardiac Toolbox / Cardiac Toolbox (eCTB)
CategoryNuclear Cardiology Imaging Software
Description

Advanced cardiovascular quantification software for SPECT and PET myocardial perfusion studies, providing 2D/3D displays, calcium scoring, strain analysis, dyssynchrony analysis, automatic reporting, and clinical decision support. Targets nuclear cardiology and cardiac imaging labs worldwide.

2NeuroQ
CategoryBrain Imaging Analysis Software
Description

Leading brain imaging analysis software providing quantification of FDG-PET, Amyloid PET, SPECT, DaTscan, and Epilepsy brain studies by comparing metabolic activity in 240 predefined brain regions to normal databases. Used by radiologists and nuclear physicians for differential diagnosis of dementia and other neurological conditions.

3Syntermed Live
CategoryCloud-Based Medical Imaging Platform
Description

HIPAA-compliant cloud-based platform providing 24/7 anywhere/anytime remote reading and reporting of nuclear cardiology studies and PET brain scans without requiring VPN or LAN connections. Enables independent physician adoption with full functionality.

4aPROMISE
CategoryOncology Imaging Software
Description

Deep learning application for accurate, efficient, and reproducible quantification of PSMA PET/CT scans. FDA-cleared medical device providing standardized quantitative reporting of prostate cancer tumor burden. Integrates with PYLARIFY AI PSMA PET imaging from Lantheus Holdings.

5SyncTool
CategoryNuclear Cardiology Imaging Software
Description

Phase analysis software for left ventricular dyssynchrony assessment to evaluate benefits of cardiac resynchronization therapy (CRT) in heart failure patients. Used in IAEA-sponsored VISION-CRT clinical trial across 9 countries.

6FlowTool
CategoryNuclear Cardiology Imaging Software
Description

Myocardial blood flow analysis tool for computing absolute blood flow and coronary/myocardial flow reserve from dynamic PET studies. Assists in detecting balanced flow reductions in endothelial disease and triple vessel disease.

7AdreView Tools
CategoryNuclear Cardiology Imaging Software
Description

Quantitative analysis tools for I-123 AdreView SPECT studies to assess myocardial sympathetic innervation, including heart-to-mediastinum ratio calculation. Helps identify mortality risk and aid in diagnosis of congestive heart failure.

8EQuAL (Extent-specified Quantified Asymmetry-of-Lobe analysis)
CategoryBrain Imaging Analysis Software
Description

NeuroQ tool for non-invasive analysis of temporal lobe epilepsy to predict likelihood of seizure-free status post-surgery based on metabolic asymmetry quantification.

9Serial Compare
CategoryBrain Imaging Analysis Software
Description

NeuroQ feature enabling comparison of two brain studies from the same patient performed at different times, showing difference images and monitoring disease progression.

10DaTscan Analysis
CategoryBrain Imaging Analysis Software
Description

NeuroQ extension providing quantified comparisons for Ioflupane I-123 (DaTscan) SPECT imaging to assist in diagnosis of Parkinsonian Syndrome or Essential Tremor.

11Amyloid Analysis (NeuroQ)
CategoryBrain Imaging Analysis Software
Description

NeuroQ extension for quantified comparisons of Amyloid PET scans using agents including Amyvid (Lilly), NeuraCeq (Piramal), and Vizamyl (GE), with SUVr calculations and Centiloid outputs.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
1GE Medical Systems
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

GE Medical Systems integrates Syntermed software including Emory Cardiac Toolbox and AdreView analysis tools with their nuclear medicine imaging systems. Long-standing OEM partnership spanning multiple product lines.

syntermed.com
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Siemens Medical Systems distributes Emory Cardiac Toolbox as part of their cardiac imaging solutions for SPECT and PET systems.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Philips Medical Systems embeds Syntermed cardiac imaging analysis software with their nuclear medicine portfolio.

Strategic tierCoreTypeOEM/ Whitelabel/ Licensing Partner
Description

Canon Medical integrates Syntermed NeuroQ brain imaging analysis software into their advanced clinical workflows for nuclear medicine.

Strategic tierMajorTypeOEM/ Whitelabel/ Licensing Partner
Description

Spectrum Dynamics distributes Emory Cardiac Toolbox with their nuclear cardiology imaging equipment.

6TTG Imaging Solutions
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

TTG Imaging Solutions distributes Syntermed products including Cardiac Toolbox for nuclear cardiac imaging as part of their comprehensive solutions.

syntermed.com
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Optum Healthcare offers Syntermed Nuclear Medicine Advanced solutions through their enterprise imaging platform for change healthcare cardiology.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

CVIT distributes Emory Cardiac Toolbox for cardiac imaging analysis as part of their nuclear medicine product offerings.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Mirada Medical distributes Syntermed diagnostic imaging software solutions for nuclear medicine applications.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Emory University developed Emory Cardiac Toolbox under Ernest V. Garcia, PhD. Syntermed was exclusive licensee for 25+ years and acquired full rights in September 2025. Ongoing R&D partnership with Emory University Nuclear Cardiology laboratory.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

IAEA sponsored VISION-CRT clinical trial uses SyncTool for LV Dyssynchrony analysis across heart failure patients in 9 countries including Italy, Algeria, South Africa, Pakistan, India, Colombia, Brazil, Mexico, and Vietnam.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Dr. Daniel Silverman, head of Neuronuclear Imaging at UCLA, collaborated on NeuroQ development and authored key reference book 'PET in the Evaluation of Alzheimer's Disease and Related Disorders'.

Strategic tierMajorTypeTechnology or Integration
Description

Syntermed's aPROMISE integrates with PYLARIFY AI PSMA PET imaging agent from Lantheus Holdings. The only FDA-cleared standardized quantitative solution for PYLARIFY PET/CT images.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Syntermed participates in SNMMI annual meetings and collaborates on education for nuclear medicine professionals.

Strategic tierMajorTypeGTM or Marketing Partner
Description

Syntermed integrates with ASNC ImageGuide Registry. Collaborative relationship for advancing nuclear cardiology standards and education.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Mediso develops dedicated PET and SPECT imaging equipment and increasingly offers integrated quantification software for preclinical and clinical nuclear imaging. It competes in adjacent nuclear medicine software while also serving as a Syntermed distribution partner.

TypeDirect peer
Description

Mirada Medical develops AI-enabled medical imaging software for nuclear medicine, radiation oncology, and radiology workflows. While Mirada is also a Syntermed distribution partner, its product portfolio (XD, RTx, DLCExpert) overlaps materially with Syntermed's quantification and reporting offering.

3MIM Software
TypeDirect peer
Description

MIM Software provides medical imaging analysis platforms for nuclear medicine, radiation oncology, and radiology, including quantification tools for SPECT, PET, and molecular imaging workflows. It is one of the closest direct competitors to Syntermed in nuclear medicine post-processing software.

TypeDirect peer
Description

Hermes Medical Solutions offers molecular imaging software for SPECT, PET, and hybrid modalities with quantification, fusion, and review tools used in nuclear medicine and oncology. It directly competes with Syntermed's Emory Cardiac Toolbox and NeuroQ in nuclear medicine post-processing.

TypeDirect peer
Description

Segami Corporation provides Oasis nuclear medicine software for SPECT, PET, and planar image processing, used widely in clinical nuclear medicine labs. It competes with Syntermed's Emory Cardiac Toolbox in cardiac and general nuclear imaging workflows.

TypeBroad incumbent
Description

Siemens syngo.via is an advanced visualization and reading platform for CT, MR, and molecular imaging, embedded across Siemens imaging installations. It competes broadly with Syntermed's cardiac and brain quantification offerings as part of a much larger OEM portfolio.

TypeBroad incumbent
Description

GE Healthcare's AW Workstation and Edison AI platform provide advanced visualization and AI-enabled quantification across CT, MR, PET, and SPECT. It competes with Syntermed as an incumbent alternative embedded within GE imaging systems, while also being a Syntermed OEM partner.

TypeDirect peer
Description

Thinking Systems provides nuclear medicine PACS and post-processing solutions including SPECT/PET quantification tools for clinical and research workflows. It overlaps with Syntermed's offerings in nuclear medicine imaging analysis, and is also a Syntermed distribution partner.

TypeBroad incumbent
Description

Philips IntelliSpace Portal is a comprehensive advanced visualization and quantification platform across CT, MR, PET, and SPECT, bundled with Philips imaging hardware. It is an incumbent alternative to Syntermed's quantification products, offering overlapping capabilities as part of a much broader enterprise imaging portfolio.

TypeBroad incumbent
Description

Canon Medical's Vitrea advanced visualization platform offers multi-modality post-processing for CT, MR, and molecular imaging. It competes with Syntermed in nuclear medicine workflows while also being a Syntermed OEM distribution partner.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration22 records

Each record includes

Title, Type, Description, Source

AI capability14 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Syntermed

Nuclear Cardiology Imaging Softwaresyntermed.com

Syntermed is an Atlanta-based medical imaging software company founded in 1999 that develops FDA-cleared quantitative analysis software for SPECT, PET, and CT imaging of the heart and brain, distributed globally through major OEMs (GE, Siemens, Philips, Canon) and value-added resellers to cardiology, nuclear medicine, radiology, and oncology practices.

What Syntermed does

Syntermed, Inc. is a privately-held medical imaging software company founded in 1999 and headquartered in Atlanta, Georgia. The company develops FDA-cleared quantitative analysis software for SPECT, PET, and CT imaging of the heart and brain, serving cardiology, nuclear medicine, radiology, and oncology practices worldwide. Its core product lines include the Emory Cardiac Toolbox (now rebranded as Cardiac Toolbox/eCTB after Syntermed acquired full IP rights in September 2025) for myocardial perfusion, calcium scoring, strain analysis, blood flow, and dyssynchrony assessment; NeuroQ for FDG-PET, Amyloid, SPECT, DaTscan, and Epilepsy brain quantification against a 240-region reference database; aPROMISE, the only FDA-cleared deep-learning application for standardized PSMA PET/CT quantification in prostate cancer; and Syntermed Live, a HIPAA-compliant cloud platform for remote reading and reporting that has hosted nearly one million studies since its 2007 launch. Supporting modules include SmartReport and Syntermed IDS for natural language structured reporting and clinical decision support (230-rule engine), SyncTool, FlowTool, AdreView Tools, and amyloidosis analysis.

Syntermed generates revenue primarily through software licensing and subscriptions sold directly, through value-added resellers, and via OEM embedding arrangements with GE Medical Systems, Siemens, Philips, Canon Medical, Spectrum Dynamics, and other imaging manufacturers. The Master Service Agreement indicates recurring subscription fees with annual billing in advance and automatic renewal, supplemented by professional services (training, installation) and 24/7 support under maintenance plans. The company holds FDA 510(k) clearances, ISO 13485:2016 certification (FM 670241), CE Mark 696491, and HIPAA compliance, and Ken Van Train has guided 22 successful 510(k) submissions. Funding has historically come from operations plus over $3.3 million in NIH SBIR/STTR grants rather than external venture capital.

The company has 11-50 employees and operates globally through a combined OEM-embedded, direct enterprise sales, and event-driven GTM motion, with active participation at SNMMI and partnerships with IAEA, Lantheus (PYLARIFY AI), ASNC ImageGuide Registry, and academic institutions including Emory University and UCLA. Leadership includes Michael Lee (Chairman and CEO), Ken Van Train (President, founder-era), and Ernest V. Garcia, PhD (Chief Scientific Advisor and Endowed Professor at Emory) as the principal scientific anchor behind the cardiac algorithms.

Syntermed firmographics

Firmographics
Name
Syntermed
Legal name
Syntermed, Inc.
Website
https://syntermed.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
1–10 employees
Short description
Syntermed is an Atlanta-based medical imaging software company founded in 1999 that develops FDA-cleared quantitative analysis software for SPECT, PET, and CT imaging of the heart and brain, distributed globally through major OEMs (GE, Siemens, Philips, Canon) and value-added resellers to cardiology, nuclear medicine, radiology, and oncology practices.
Ownership category
akta.pro rank

Syntermed industry classification

Industry
Product category
Nuclear Cardiology Imaging Software
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAE
Nuclear Medicine & Molecular Imaging (SPECT/PET)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAKABAE
Non-Invasive Cardiac Imaging (Echo/CT/MRI/Nuclear)

Keywords

  • Nuclear cardiology software
  • Medical imaging analytics
  • Brain imaging quantification
  • Cardiac SPECT PET analysis
  • Radiology decision support

Where Syntermed is headquartered

Location

Headquarters

HQ city
Atlanta
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Syntermed business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Software Licensing and Subscriptions: Syntermed licenses its medical imaging software products (Emory Toolbox, NeuroQ) through OEM partnerships, direct sales, and value-added resellers. The Master Service Agreement indicates recurring subscription fees with automatic renewal terms and per-order pricing structures.
  2. Professional Services and Support: Training, installation, and technical support services including on-site training for additional fees and 24/7 support for customers on Software Maintenance Plans.
  3. OEM/Embedded Licensing: Software embedded and integrated by OEM partners including GE, Siemens, Philips, Canon Medical, and others for distribution with their imaging systems.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise/Lab Licensing

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Syntermed product offering

Product offering

Core offering

Syntermed develops, licenses, and supports FDA-cleared medical imaging software for the quantitative analysis of SPECT, PET, and CT scans of the heart and brain. Its flagship offerings include the Emory Cardiac Toolbox (Cardiac Toolbox / eCTB) for nuclear cardiology, NeuroQ for brain imaging quantification, Syntermed Live for cloud-based remote reading, and aPROMISE for PSMA PET/CT prostate cancer assessment. The company distributes its software through OEM imaging system providers, value-added resellers, and direct sales to cardiology, nuclear medicine, and radiology labs worldwide.

Product overview

Syntermed is a medical imaging software company offering a platform of specialized products for nuclear cardiology, neuroradiology, and oncology imaging analysis. The core products include Emory Cardiac Toolbox/Cardiac Toolbox (eCTB) for cardiovascular imaging quantification, NeuroQ for brain imaging analysis, and Syntermed Live for cloud-based remote reading. Additional specialized modules include SmartReport and Syntermed IDS for automated reporting and clinical decision support, SyncTool and FlowTool for cardiac dyssynchrony and blood flow analysis, AdreView Tools for sympathetic innervation imaging, Calcium Scoring and Amyloidosis Analysis for cardiac CT/PET analysis, and aPROMISE for PSMA PET/CT quantification in oncology. The company also provides advanced brain imaging tools including EQuAL for epilepsy planning, Serial Compare for longitudinal studies, DaTscan Analysis, and Amyloid Analysis within the NeuroQ platform.

Differentiator

Problem solved

Functional benefit

Brands

  • Cardiac Toolbox: Advanced multi-modality solution for nuclear cardiology imaging analysis, formerly known as Emory Cardiac Toolbox. Provides tools for SPECT, PET, CT, reporting, CFR, and remote reading.
  • NeuroQ
  • Syntermed Live
  • SmartReport
  • Syntermed IDS
  • aPROMISE

Products and services

  • Emory Cardiac Toolbox / Cardiac Toolbox (eCTB) Advanced cardiovascular quantification software for SPECT and PET myocardial perfusion studies, providing 2D/3D displays, calcium scoring, strain analysis, dyssynchrony analysis, automatic reporting, and clinical decision support. Targets nuclear cardiology and cardiac imaging labs worldwide.
  • NeuroQ Leading brain imaging analysis software providing quantification of FDG-PET, Amyloid PET, SPECT, DaTscan, and Epilepsy brain studies by comparing metabolic activity in 240 predefined brain regions to normal databases. Used by radiologists and nuclear physicians for differential diagnosis of dementia and other neurological conditions.
  • Syntermed Live HIPAA-compliant cloud-based platform providing 24/7 anywhere/anytime remote reading and reporting of nuclear cardiology studies and PET brain scans without requiring VPN or LAN connections. Enables independent physician adoption with full functionality.
  • aPROMISE Deep learning application for accurate, efficient, and reproducible quantification of PSMA PET/CT scans. FDA-cleared medical device providing standardized quantitative reporting of prostate cancer tumor burden. Integrates with PYLARIFY AI PSMA PET imaging from Lantheus Holdings.
  • SyncTool Phase analysis software for left ventricular dyssynchrony assessment to evaluate benefits of cardiac resynchronization therapy (CRT) in heart failure patients. Used in IAEA-sponsored VISION-CRT clinical trial across 9 countries.
  • FlowTool Myocardial blood flow analysis tool for computing absolute blood flow and coronary/myocardial flow reserve from dynamic PET studies. Assists in detecting balanced flow reductions in endothelial disease and triple vessel disease.
  • AdreView Tools Quantitative analysis tools for I-123 AdreView SPECT studies to assess myocardial sympathetic innervation, including heart-to-mediastinum ratio calculation. Helps identify mortality risk and aid in diagnosis of congestive heart failure.
  • EQuAL (Extent-specified Quantified Asymmetry-of-Lobe analysis) NeuroQ tool for non-invasive analysis of temporal lobe epilepsy to predict likelihood of seizure-free status post-surgery based on metabolic asymmetry quantification.
  • Serial Compare NeuroQ feature enabling comparison of two brain studies from the same patient performed at different times, showing difference images and monitoring disease progression.
  • DaTscan Analysis NeuroQ extension providing quantified comparisons for Ioflupane I-123 (DaTscan) SPECT imaging to assist in diagnosis of Parkinsonian Syndrome or Essential Tremor.
  • Amyloid Analysis (NeuroQ) NeuroQ extension for quantified comparisons of Amyloid PET scans using agents including Amyvid (Lilly), NeuraCeq (Piramal), and Vizamyl (GE), with SUVr calculations and Centiloid outputs.

Quantifiable outcome

  • Dementia diagnostic accuracy increases from ~70% visual read to ~90% with FDG-PET + NeuroQ quantification
  • +3 more outcomes

Companies that use Syntermed

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles4 records

Syntermed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration22 records

AI capability14 records

Feature8 records

Syntermed partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered core and major.

  • GE Medical SystemscoreOEM/ Whitelabel/ Licensing PartnerGE Medical Systems integrates Syntermed software including Emory Cardiac Toolbox and AdreView analysis tools with their nuclear medicine imaging systems. Long-standing OEM partnership spanning multiple product lines.
  • Siemens Medical SystemscoreOEM/ Whitelabel/ Licensing PartnerSiemens Medical Systems distributes Emory Cardiac Toolbox as part of their cardiac imaging solutions for SPECT and PET systems.
  • Philips Medical SystemscoreOEM/ Whitelabel/ Licensing PartnerPhilips Medical Systems embeds Syntermed cardiac imaging analysis software with their nuclear medicine portfolio.
  • Canon Medical SystemscoreOEM/ Whitelabel/ Licensing PartnerCanon Medical integrates Syntermed NeuroQ brain imaging analysis software into their advanced clinical workflows for nuclear medicine.
  • Spectrum DynamicsmajorOEM/ Whitelabel/ Licensing PartnerSpectrum Dynamics distributes Emory Cardiac Toolbox with their nuclear cardiology imaging equipment.
  • TTG Imaging SolutionsmajorChannel Partner/ Reseller/ DistributorTTG Imaging Solutions distributes Syntermed products including Cardiac Toolbox for nuclear cardiac imaging as part of their comprehensive solutions.
  • Optum HealthcaremajorChannel Partner/ Reseller/ DistributorOptum Healthcare offers Syntermed Nuclear Medicine Advanced solutions through their enterprise imaging platform for change healthcare cardiology.
  • CVITmajorChannel Partner/ Reseller/ DistributorCVIT distributes Emory Cardiac Toolbox for cardiac imaging analysis as part of their nuclear medicine product offerings.
  • Mirada MedicalmajorChannel Partner/ Reseller/ DistributorMirada Medical distributes Syntermed diagnostic imaging software solutions for nuclear medicine applications.
  • Emory UniversitycoreStrategic or Co-development PartnerEmory University developed Emory Cardiac Toolbox under Ernest V. Garcia, PhD. Syntermed was exclusive licensee for 25+ years and acquired full rights in September 2025. Ongoing R&D partnership with Emory University Nuclear Cardiology laboratory.
  • International Atomic Energy Agency (IAEA)majorStrategic or Co-development PartnerIAEA sponsored VISION-CRT clinical trial uses SyncTool for LV Dyssynchrony analysis across heart failure patients in 9 countries including Italy, Algeria, South Africa, Pakistan, India, Colombia, Brazil, Mexico, and Vietnam.
  • UCLA David Geffen School of MedicinecoreStrategic or Co-development PartnerDr. Daniel Silverman, head of Neuronuclear Imaging at UCLA, collaborated on NeuroQ development and authored key reference book 'PET in the Evaluation of Alzheimer's Disease and Related Disorders'.
  • Lantheus Holdings, Inc.majorTechnology or IntegrationSyntermed's aPROMISE integrates with PYLARIFY AI PSMA PET imaging agent from Lantheus Holdings. The only FDA-cleared standardized quantitative solution for PYLARIFY PET/CT images.
  • Society of Nuclear Medicine and Molecular Imaging (SNMMI)majorGTM or Marketing PartnerSyntermed participates in SNMMI annual meetings and collaborates on education for nuclear medicine professionals.
  • American Society of Nuclear Cardiology (ASNC)majorGTM or Marketing PartnerSyntermed integrates with ASNC ImageGuide Registry. Collaborative relationship for advancing nuclear cardiology standards and education.

Scale indicators8 records

Recent moves5 records

Expansion highlights6 records

Syntermed competitors and assessment

Company assessment

Emerging players

  • Mediso Medical Imaging Systems: Mediso develops dedicated PET and SPECT imaging equipment and increasingly offers integrated quantification software for preclinical and clinical nuclear imaging. It competes in adjacent nuclear medicine software while also serving as a Syntermed distribution partner.

Direct peers

  • Mirada Medical: Mirada Medical develops AI-enabled medical imaging software for nuclear medicine, radiation oncology, and radiology workflows. While Mirada is also a Syntermed distribution partner, its product portfolio (XD, RTx, DLCExpert) overlaps materially with Syntermed's quantification and reporting offering.
  • MIM Software: MIM Software provides medical imaging analysis platforms for nuclear medicine, radiation oncology, and radiology, including quantification tools for SPECT, PET, and molecular imaging workflows. It is one of the closest direct competitors to Syntermed in nuclear medicine post-processing software.
  • Hermes Medical Solutions: Hermes Medical Solutions offers molecular imaging software for SPECT, PET, and hybrid modalities with quantification, fusion, and review tools used in nuclear medicine and oncology. It directly competes with Syntermed's Emory Cardiac Toolbox and NeuroQ in nuclear medicine post-processing.
  • Segami Corporation: Segami Corporation provides Oasis nuclear medicine software for SPECT, PET, and planar image processing, used widely in clinical nuclear medicine labs. It competes with Syntermed's Emory Cardiac Toolbox in cardiac and general nuclear imaging workflows.
  • Thinking Systems: Thinking Systems provides nuclear medicine PACS and post-processing solutions including SPECT/PET quantification tools for clinical and research workflows. It overlaps with Syntermed's offerings in nuclear medicine imaging analysis, and is also a Syntermed distribution partner.

Broad incumbents

  • Siemens Healthineers (syngo.via): Siemens syngo.via is an advanced visualization and reading platform for CT, MR, and molecular imaging, embedded across Siemens imaging installations. It competes broadly with Syntermed's cardiac and brain quantification offerings as part of a much larger OEM portfolio.
  • GE Healthcare (AW Workstation / Edison): GE Healthcare's AW Workstation and Edison AI platform provide advanced visualization and AI-enabled quantification across CT, MR, PET, and SPECT. It competes with Syntermed as an incumbent alternative embedded within GE imaging systems, while also being a Syntermed OEM partner.
  • Philips IntelliSpace Portal: Philips IntelliSpace Portal is a comprehensive advanced visualization and quantification platform across CT, MR, PET, and SPECT, bundled with Philips imaging hardware. It is an incumbent alternative to Syntermed's quantification products, offering overlapping capabilities as part of a much broader enterprise imaging portfolio.
  • Canon Medical (Vitrea): Canon Medical's Vitrea advanced visualization platform offers multi-modality post-processing for CT, MR, and molecular imaging. It competes with Syntermed in nuclear medicine workflows while also being a Syntermed OEM distribution partner.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Syntermed social profiles

Digital presence

Syntermed compliance and trust

Trust signal

Compliance7 records

Syntermed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Syntermed leadership team

Management profile

Number of profiles

Profiles10 records

Syntermed funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Syntermed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syntermed

What does Syntermed do?

Syntermed develops, licenses, and supports FDA-cleared medical imaging software for the quantitative analysis of SPECT, PET, and CT scans of the heart and brain. Its flagship offerings include the Emory Cardiac Toolbox (Cardiac Toolbox / eCTB) for nuclear cardiology, NeuroQ for brain imaging quantification, Syntermed Live for cloud-based remote reading, and aPROMISE for PSMA PET/CT prostate cancer assessment. The company distributes its software through OEM imaging system providers, value-added resellers, and direct sales to cardiology, nuclear medicine, and radiology labs worldwide.

Is Syntermed a public or private company?

Syntermed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Syntermed founded?

Syntermed was founded in 1999. It employs 1 to 10 people.

Where is Syntermed based?

Syntermed is headquartered in Atlanta, United States, in the North America region.

How does Syntermed make money?

Three revenue lines are on record. Software Licensing and Subscriptions are the primary driver. The others are professional Services and Support and OEM/Embedded Licensing.

Who are Syntermed's main competitors?

Mediso Medical Imaging Systems is listed as an emerging player. Direct peers are Mirada Medical, MIM Software, Hermes Medical Solutions, Segami Corporation and Thinking Systems. Broad incumbents are Siemens Healthineers (syngo.via), GE Healthcare (AW Workstation / Edison), Philips IntelliSpace Portal and Canon Medical (Vitrea).

Does Syntermed have an API?

No public API is recorded for Syntermed.

What industry is Syntermed in?

Syntermed's product category is Nuclear Cardiology Imaging Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAE, Nuclear Medicine & Molecular Imaging (SPECT/PET). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals